Cargando…
Lack of confirmatory data following Article 12 MRL reviews for 2,4‐d, fenhexamid and iprovalicarb
The European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 reviews under Regulation (EC) No 396/2005 for the following substances/commodity combination: 2,4‐d on buckwheat and other pseudo‐...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546792/ https://www.ncbi.nlm.nih.gov/pubmed/34729094 http://dx.doi.org/10.2903/j.efsa.2021.6910 |
Ejemplares similares
-
Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
Publicado: (2023) -
Evaluation of confirmatory data following the Article 12 MRL review for pendimethalin
por: Brancato, Alba, et al.
Publicado: (2018) -
Evaluation of confirmatory data following the Article 12 MRL review for cyazofamid
por: Anastassiadou, Maria, et al.
Publicado: (2018) -
Evaluation of confirmatory data following the Article 12 MRL review for picolinafen
por: Anastassiadou, Maria, et al.
Publicado: (2018) -
Evaluation of confirmatory data following the Article 12 MRL review for teflubenzuron
por: Brancato, Alba, et al.
Publicado: (2018)